Literature DB >> 26501953

Long-term culture and expansion of primary human hepatocytes.

Gahl Levy1, David Bomze1, Stefan Heinz2, Sarada Devi Ramachandran3, Astrid Noerenberg2, Merav Cohen1,4, Oren Shibolet5, Ella Sklan6, Joris Braspenning3,7, Yaakov Nahmias1,4.   

Abstract

Hepatocytes have a critical role in metabolism, but their study is limited by the inability to expand primary hepatocytes in vitro while maintaining proliferative capacity and metabolic function. Here we describe the oncostatin M (OSM)-dependent expansion of primary human hepatocytes by low expression of the human papilloma virus (HPV) genes E6 and E7 coupled with inhibition of epithelial-to-mesenchymal transition. We show that E6 and E7 expression upregulates the OSM receptor gp130 and that OSM stimulation induces hepatocytes to expand for up to 40 population doublings, producing 1013 to 1016 cells from a single human hepatocyte isolate. OSM removal induces differentiation into metabolically functional, polarized hepatocytes with functional bile canaliculi. Differentiated hepatocytes show transcriptional and toxicity profiles and cytochrome P450 induction similar to those of primary human hepatocytes. Replication and infectivity of hepatitis C virus (HCV) in differentiated hepatocytes are similar to those of Huh7.5.1 human hepatoma cells. These results offer a means of expanding human hepatocytes of different genetic backgrounds for research, clinical applications and pharmaceutical development.

Entities:  

Year:  2015        PMID: 26501953     DOI: 10.1038/nbt.3377

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  50 in total

1.  Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes.

Authors:  M Teresa Donato; Nuria Jiménez; José V Castell; M José Gómez-Lechón
Journal:  Drug Metab Dispos       Date:  2004-07       Impact factor: 3.922

2.  C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration.

Authors:  C Trautwein; T Rakemann; A Pietrangelo; J Plümpe; G Montosi; M P Manns
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

3.  Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation.

Authors:  I J Schippers; H Moshage; H Roelofsen; M Müller; H S Heymans; M Ruiters; F Kuipers
Journal:  Cell Biol Toxicol       Date:  1997-07       Impact factor: 6.691

Review 4.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.

Authors:  André Guillouzo; Anne Corlu; Caroline Aninat; Denise Glaise; Fabrice Morel; Christiane Guguen-Guillouzo
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

5.  Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays.

Authors:  Alexandra Burkard; Caroline Dähn; Stefan Heinz; Anne Zutavern; Vera Sonntag-Buck; Daniel Maltman; Stefan Przyborski; Nicola J Hewitt; Joris Braspenning
Journal:  Xenobiotica       Date:  2012-04-24       Impact factor: 1.908

6.  Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Authors:  Alexander Ploss; Salman R Khetani; Christopher T Jones; Andrew J Syder; Kartik Trehan; Valeriya A Gaysinskaya; Kathy Mu; Kimberly Ritola; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Stimulation of growth of primary cultured adult rat hepatocytes without growth factors by coculture with nonparenchymal liver cells.

Authors:  S Shimaoka; T Nakamura; A Ichihara
Journal:  Exp Cell Res       Date:  1987-09       Impact factor: 3.905

8.  Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice.

Authors:  Koji Nakamura; Hidenori Nonaka; Hiroki Saito; Minoru Tanaka; Atsushi Miyajima
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

9.  Role for TBC1D20 and Rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A.

Authors:  Inbar Nevo-Yassaf; Yakey Yaffe; Meital Asher; Orly Ravid; Sharon Eizenberg; Yoav I Henis; Yaakov Nahmias; Koret Hirschberg; Ella H Sklan
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

10.  Accurate prediction of drug-induced liver injury using stem cell-derived populations.

Authors:  Dagmara Szkolnicka; Sarah L Farnworth; Baltasar Lucendo-Villarin; Christopher Storck; Wenli Zhou; John P Iredale; Oliver Flint; David C Hay
Journal:  Stem Cells Transl Med       Date:  2013-12-27       Impact factor: 6.940

View more
  49 in total

1.  From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.

Authors:  Sreenivasa C Ramaiahgari; Suramya Waidyanatha; Darlene Dixon; Michael J DeVito; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

Review 2.  Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.

Authors:  Chen Chen; Alejandro Soto-Gutierrez; Pedro M Baptista; Bart Spee
Journal:  Gastroenterology       Date:  2018-02-08       Impact factor: 22.682

Review 3.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.

Authors:  Shyam Sundhar Bale; Laura Moore; Martin Yarmush; Rohit Jindal
Journal:  Tissue Eng Part B Rev       Date:  2016-06-01       Impact factor: 6.389

4.  The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.

Authors:  Juan M Adrian-Segarra; Natalie Schindler; Praveen Gajawada; Holger Lörchner; Thomas Braun; Jochen Pöling
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

Review 5.  Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.

Authors:  Avner Ehrlich; Daniel Duche; Gladys Ouedraogo; Yaakov Nahmias
Journal:  Annu Rev Biomed Eng       Date:  2019-06-04       Impact factor: 9.590

6.  Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Authors:  Yuchen Xia; Xiaoming Cheng; Yao Li; Kristin Valdez; Weiping Chen; T Jake Liang
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  Harnessing endogenous signals from hepatocytes using a low volume multi-well plate.

Authors:  Pantea Gheibi; Kyung Jin Son; Gulnaz Stybayeva; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2017-05-22       Impact factor: 2.192

Review 8.  Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

Authors:  Naiem T Issa; Henri Wathieu; Abiola Ojo; Stephen W Byers; Sivanesan Dakshanamurthy
Journal:  Curr Drug Metab       Date:  2017       Impact factor: 3.731

9.  Microphysiological flux balance platform unravels the dynamics of drug induced steatosis.

Authors:  Avner Ehrlich; Sabina Tsytkin-Kirschenzweig; Konstantinos Ioannidis; Muneef Ayyash; Anne Riu; Reine Note; Gladys Ouedraogo; Jan Vanfleteren; Merav Cohen; Yaakov Nahmias
Journal:  Lab Chip       Date:  2018-08-21       Impact factor: 6.799

Review 10.  Experimental models of hepatitis B and C - new insights and progress.

Authors:  Emmanuel Thomas; T Jake Liang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.